pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

STAT readers weigh in on MD vs DO training, AI accountability and surrogacy in medicine

Sep 5, 2026·read at STAT ↗Neutral

STAT’s First Opinion platform invites letters that respond to its essays, and a recent submission addresses several hot topics in health care.

The writer acknowledges the bias that osteopathic graduates face in residency placement, but argues they should not abandon the unique principles and practices they bring to the system.

On the issue of artificial intelligence, the letter stresses that a simple click, signature, or brief review should not shift legal or ethical responsibility from AI developers to the physicians who use the tools.

The response also touches on broader concerns such as surrogacy, urging continued dialogue on these complex matters.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more”

read at STAT ↗
2,852 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
UNIQUE2NOVOWM TECHNOLOGY, INC.
topics
Psychiatry & CNS6Major Depression2Alzheimer's DiseaseDrug ShortageInfectious DiseaseOphthalmologySchizophrenia

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 20h agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • Aug 17How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and MedicineBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Aug 3Novo’s late-stage IL-6 stumble shakes inflammation spaceBioSpace